These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 20859956

  • 1. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF.
    Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
    [Abstract] [Full Text] [Related]

  • 2. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
    Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M.
    Cancer Res; 2007 Jul 01; 67(13):6092-9. PubMed ID: 17616664
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun 01; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.
    Gastroenterology; 2008 Jul 01; 135(1):257-69. PubMed ID: 18555017
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ.
    Cell Biochem Biophys; 2012 Jan 01; 62(1):237-44. PubMed ID: 21847633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.
    Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881
    [Abstract] [Full Text] [Related]

  • 9. [The relationship between microRNA-18 and BTG2 in the carcinogenesis of hepatocellular carcinoma].
    Li Q, Wang G, Zhang ZM.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan 12; 17(1):42-5. PubMed ID: 19203451
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
    Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL.
    Biochem Biophys Res Commun; 2008 Oct 24; 375(3):315-20. PubMed ID: 18692484
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.
    J Gastroenterol Hepatol; 2013 Mar 24; 28(3):565-75. PubMed ID: 22989374
    [Abstract] [Full Text] [Related]

  • 14. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT, Ching AK, Chan AW, Wong QW, Wong CK, To KF, Wong N.
    Carcinogenesis; 2012 Jun 24; 33(6):1134-41. PubMed ID: 22431718
    [Abstract] [Full Text] [Related]

  • 15. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.
    Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283
    [Abstract] [Full Text] [Related]

  • 16. [MicroRNA profiling in patients with hepatocellular carcinoma].
    Wang CX, Song W, Li ZJ, Song B, Wu DH, Sun AM, Chen LH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 15; 30(5):976-7. PubMed ID: 20501372
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
    Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, Wong N.
    Clin Cancer Res; 2010 Feb 01; 16(3):867-75. PubMed ID: 20103675
    [Abstract] [Full Text] [Related]

  • 19. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.
    J Gastroenterol Hepatol; 2011 Nov 01; 26(11):1630-7. PubMed ID: 21557766
    [Abstract] [Full Text] [Related]

  • 20. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI.
    FEBS Lett; 2012 Sep 21; 586(19):3309-16. PubMed ID: 22819824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.